Cargando…

Analysis of filaggrin 2 gene polymorphisms in patients with atopic dermatitis()()

BACKGROUND: Polymorphisms of the filaggrin 2 gene (rs 12568784 and rs 16899374) are associated with persistent atopic dermatitis in African American patients. Filaggrin 2 is a protein with a function similar to filaggrin and also encoded in the epidermal differentiation complex on chromosome 1q21. O...

Descripción completa

Detalles Bibliográficos
Autores principales: Hertz, Amanda, Azulay-Abulafia, Luna, Nascimento, Adriana Paulino do, Ohara, Cintya Yumi, Kuschnir, Fabio Chigres, Porto, Luís Cristovão
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175100/
https://www.ncbi.nlm.nih.gov/pubmed/32151410
http://dx.doi.org/10.1016/j.abd.2019.07.002
_version_ 1783524758878420992
author Hertz, Amanda
Azulay-Abulafia, Luna
Nascimento, Adriana Paulino do
Ohara, Cintya Yumi
Kuschnir, Fabio Chigres
Porto, Luís Cristovão
author_facet Hertz, Amanda
Azulay-Abulafia, Luna
Nascimento, Adriana Paulino do
Ohara, Cintya Yumi
Kuschnir, Fabio Chigres
Porto, Luís Cristovão
author_sort Hertz, Amanda
collection PubMed
description BACKGROUND: Polymorphisms of the filaggrin 2 gene (rs 12568784 and rs 16899374) are associated with persistent atopic dermatitis in African American patients. Filaggrin 2 is a protein with a function similar to filaggrin and also encoded in the epidermal differentiation complex on chromosome 1q21. OBJECTIVE: To evaluate the polymorphisms in the filaggrin 2 gene (rs 12568784 and rs 16899374) in children and adults with atopic dermatitis and to verify the association of these with the severity of the clinical picture, presence of other allergic diseases, and socio-demographic factors. METHOD: The study was carried out with patients and control group. Questionnaires were used to evaluate ethnicity, sex, age, family history, scoring, atopic dermatitis (SCORAD), among other parameters. Genotyping of the filaggrin 2 gene was performed by real-time polymerase chain reaction. RESULTS: Forty-eight patients and 83 controls were evaluated. No correlation was found between the variables studied in patients with atopic dermatitis and polymorphisms, no significant difference between the prevalence of polymorphisms in the patients and in the control group p > 0.05. STUDY LIMITS: The exclusive use of self-reported ethnicity information and the sample size. RESULTS: The results of this work can be an incentive for the study of the polymorphisms in atopic dermaititis, considering the characteristic of the Brazilian multi ethnic population. CONCLUSION: This is an unpublished work in Brazil and the first study in the world to have a control group to evaluate alterations in the gene of filaggrin 2.
format Online
Article
Text
id pubmed-7175100
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Sociedade Brasileira de Dermatologia
record_format MEDLINE/PubMed
spelling pubmed-71751002020-04-22 Analysis of filaggrin 2 gene polymorphisms in patients with atopic dermatitis()() Hertz, Amanda Azulay-Abulafia, Luna Nascimento, Adriana Paulino do Ohara, Cintya Yumi Kuschnir, Fabio Chigres Porto, Luís Cristovão An Bras Dermatol Investigation BACKGROUND: Polymorphisms of the filaggrin 2 gene (rs 12568784 and rs 16899374) are associated with persistent atopic dermatitis in African American patients. Filaggrin 2 is a protein with a function similar to filaggrin and also encoded in the epidermal differentiation complex on chromosome 1q21. OBJECTIVE: To evaluate the polymorphisms in the filaggrin 2 gene (rs 12568784 and rs 16899374) in children and adults with atopic dermatitis and to verify the association of these with the severity of the clinical picture, presence of other allergic diseases, and socio-demographic factors. METHOD: The study was carried out with patients and control group. Questionnaires were used to evaluate ethnicity, sex, age, family history, scoring, atopic dermatitis (SCORAD), among other parameters. Genotyping of the filaggrin 2 gene was performed by real-time polymerase chain reaction. RESULTS: Forty-eight patients and 83 controls were evaluated. No correlation was found between the variables studied in patients with atopic dermatitis and polymorphisms, no significant difference between the prevalence of polymorphisms in the patients and in the control group p > 0.05. STUDY LIMITS: The exclusive use of self-reported ethnicity information and the sample size. RESULTS: The results of this work can be an incentive for the study of the polymorphisms in atopic dermaititis, considering the characteristic of the Brazilian multi ethnic population. CONCLUSION: This is an unpublished work in Brazil and the first study in the world to have a control group to evaluate alterations in the gene of filaggrin 2. Sociedade Brasileira de Dermatologia 2020 2020-01-25 /pmc/articles/PMC7175100/ /pubmed/32151410 http://dx.doi.org/10.1016/j.abd.2019.07.002 Text en © 2020 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Investigation
Hertz, Amanda
Azulay-Abulafia, Luna
Nascimento, Adriana Paulino do
Ohara, Cintya Yumi
Kuschnir, Fabio Chigres
Porto, Luís Cristovão
Analysis of filaggrin 2 gene polymorphisms in patients with atopic dermatitis()()
title Analysis of filaggrin 2 gene polymorphisms in patients with atopic dermatitis()()
title_full Analysis of filaggrin 2 gene polymorphisms in patients with atopic dermatitis()()
title_fullStr Analysis of filaggrin 2 gene polymorphisms in patients with atopic dermatitis()()
title_full_unstemmed Analysis of filaggrin 2 gene polymorphisms in patients with atopic dermatitis()()
title_short Analysis of filaggrin 2 gene polymorphisms in patients with atopic dermatitis()()
title_sort analysis of filaggrin 2 gene polymorphisms in patients with atopic dermatitis()()
topic Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175100/
https://www.ncbi.nlm.nih.gov/pubmed/32151410
http://dx.doi.org/10.1016/j.abd.2019.07.002
work_keys_str_mv AT hertzamanda analysisoffilaggrin2genepolymorphismsinpatientswithatopicdermatitis
AT azulayabulafialuna analysisoffilaggrin2genepolymorphismsinpatientswithatopicdermatitis
AT nascimentoadrianapaulinodo analysisoffilaggrin2genepolymorphismsinpatientswithatopicdermatitis
AT oharacintyayumi analysisoffilaggrin2genepolymorphismsinpatientswithatopicdermatitis
AT kuschnirfabiochigres analysisoffilaggrin2genepolymorphismsinpatientswithatopicdermatitis
AT portoluiscristovao analysisoffilaggrin2genepolymorphismsinpatientswithatopicdermatitis